Clinical trial
DS-3201b and Irinotecan for Patients With Recurrent Small Cell Lung Cancer
NCT03879798
Study timeline
Study start (actual)2019-03-15Date precision: day
Registry last updated2024-10-10
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Small Cell Lung Cancerunresolved
Interventions
DS-3201bDRUG
irinotecanDRUG · verified · RxNorm: irinotecan
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03879798 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.